Literature DB >> 19106607

Loss of p21 CDKN1A impairs entry to quiescence and activates a DNA damage response in normal fibroblasts induced to quiescence.

Paola Perucca1, Ornella Cazzalini, Mark Madine, Monica Savio, Ronal Alfred Laskey, Vanio Vannini, Ennio Prosperi, Lucia Anna Stivala.   

Abstract

The cell cycle inhibitor p21(CDKN1A) induces cell cycle arrest under different conditions, including senescence and terminal differentiation. Still debated is its involvement in the reversible transition from proliferation to a non-dividing quiescent state (G(0)), in which a significant role has been attributed to cell cycle inhibitor p27(CDKN1B). Here we provide evidence showing that high p21 protein levels are necessary to enter and maintain the quiescence state following contact inhibition and growth factor withdrawal. In fact, entry into quiescence was impaired, both in human fibroblasts in which p21 gene has been deleted, or protein expression knocked-down by RNA interference. Importantly, in the absence of p21, human fibroblasts activate a DNA damage-like signalling pathway, as shown by phosphorylation of histone H2AX and Chk1 proteins. In addition, we show that in the absence of p21, checkpoint is activated by an unscheduled entry into S phase, with a reduced efficiency in DNA maturation, in the presence of high c-myc protein levels. These results highlight the role of p21 in counteracting inappropriate proliferation stimuli for genome stability maintenance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19106607     DOI: 10.4161/cc.8.1.7507

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  37 in total

1.  Activation of postnatal neural stem cells requires nuclear receptor TLX.

Authors:  Wenze Niu; Yuhua Zou; Chengcheng Shen; Chun-Li Zhang
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Rapamycin induces pluripotent genes associated with avoidance of replicative senescence.

Authors:  Tatiana V Pospelova; Tatiana V Bykova; Svetlana G Zubova; Natalia V Katolikova; Natalia M Yartzeva; Valery A Pospelov
Journal:  Cell Cycle       Date:  2013-12-02       Impact factor: 4.534

Review 3.  Cell cycle proliferation decisions: the impact of single cell analyses.

Authors:  Jacob P Matson; Jeanette G Cook
Journal:  FEBS J       Date:  2016-10-05       Impact factor: 5.542

Review 4.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

5.  The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.

Authors:  Yuhua Zou; Wenze Niu; Song Qin; Michael Downes; Dennis K Burns; Chun-Li Zhang
Journal:  Mol Cell Biol       Date:  2012-10-01       Impact factor: 4.272

6.  In vivo analysis of γH2AX+ cells in skeletal muscle from aged and obese humans.

Authors:  Cory M Dungan; Bailey D Peck; R Grace Walton; Zhengyan Huang; Marcas M Bamman; Philip A Kern; Charlotte A Peterson
Journal:  FASEB J       Date:  2020-04-04       Impact factor: 5.191

7.  Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance.

Authors:  Nathan Moore; Stephen Lyle
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

8.  New biomarkers probing depth of cell senescence assessed by laser scanning cytometry.

Authors:  Hong Zhao; H Dorota Halicka; Frank Traganos; Ellen Jorgensen; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-11       Impact factor: 4.355

9.  Pseudo-DNA damage response in senescent cells.

Authors:  Tatyana V Pospelova; Zoya N Demidenko; Elena I Bukreeva; Valery A Pospelov; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-12-01       Impact factor: 4.534

Review 10.  Enhanced cartilage repair in 'healer' mice-New leads in the search for better clinical options for cartilage repair.

Authors:  Jamie Fitzgerald
Journal:  Semin Cell Dev Biol       Date:  2016-04-26       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.